November 7, 2011
Takeda Pharmaceutical announced on November 4 that in response to its acquisition of Switzerland’s Nycomed, it has established the new positions of Chief Medical & Scientific Officer (CMSO) and Chief Commercial Officer (CCO). The move is aimed at strengthening the...read more